These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9010233)

  • 1. Transcriptional down-regulation of myogenin expression is associated with v-ras-induced block of differentiation in unestablished quail muscle cells.
    Russo S; Tatò F; Grossi M
    Oncogene; 1997 Jan; 14(1):63-73. PubMed ID: 9010233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective repression of myoD transcription by v-Myc prevents terminal differentiation of quail embryo myoblasts transformed by the MC29 strain of avian myelocytomatosis virus.
    La Rocca SA; Vannucchi S; Pompili M; Pinney DF; Emerson CP; Grossi M; Tatò F
    Oncogene; 2002 Jul; 21(31):4838-42. PubMed ID: 12101422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. v-Src inhibits myogenic differentiation by interfering with the regulatory network of muscle-specific transcriptional activators at multiple levels.
    Falcone G; Ciuffini L; Gauzzi MC; Provenzano C; Strano S; Gallo R; Castellani L; Alemà S
    Oncogene; 2003 Nov; 22(51):8302-15. PubMed ID: 14614454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myogenin expression is necessary for commitment to differentiation and is closely related to src tyrosine kinase activity in quail myoblasts transformed with Rous sarcoma virus.
    Hirayama E; Isobe A; Okamoto H; Nishioka M; Kim J
    Eur J Cell Biol; 1997 Feb; 72(2):133-41. PubMed ID: 9157009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-Myc inhibits myogenic differentiation and myoD expression by a mechanism which can be dissociated from cell transformation.
    La Rocca SA; Crouch DH; Gillespie DA
    Oncogene; 1994 Dec; 9(12):3499-508. PubMed ID: 7970710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myoblast alpha v beta3 integrin levels are controlled by transcriptional regulation of expression of the beta3 subunit and down-regulation of beta3 subunit expression is required for skeletal muscle cell differentiation.
    Blaschuk KL; Guérin C; Holland PC
    Dev Biol; 1997 Apr; 184(2):266-77. PubMed ID: 9133434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone morphogenetic protein-2 inhibits terminal differentiation of myogenic cells by suppressing the transcriptional activity of MyoD and myogenin.
    Katagiri T; Akiyama S; Namiki M; Komaki M; Yamaguchi A; Rosen V; Wozney JM; Fujisawa-Sehara A; Suda T
    Exp Cell Res; 1997 Feb; 230(2):342-51. PubMed ID: 9024793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. v-jun oncogene prevents terminal differentiation and suppresses muscle-specific gene expression in ASV-17-infected muscle cells.
    Grossi M; Calconi A; Tatò F
    Oncogene; 1991 Oct; 6(10):1767-73. PubMed ID: 1923502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of myogenic differentiation by the H-ras oncogene is associated with the down regulation of the MyoD1 gene.
    Konieczny SF; Drobes BL; Menke SL; Taparowsky EJ
    Oncogene; 1989 Apr; 4(4):473-81. PubMed ID: 2654809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional activation of the myogenin gene by MEF2-mediated recruitment of myf5 is inhibited by adenovirus E1A protein.
    Johanson M; Meents H; Ragge K; Buchberger A; Arnold HH; Sandmöller A
    Biochem Biophys Res Commun; 1999 Nov; 265(1):222-32. PubMed ID: 10548518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive regulation of skeletal myogenesis by R-Ras.
    Suzuki J; Kaziro Y; Koide H
    Oncogene; 2000 Feb; 19(9):1138-46. PubMed ID: 10713701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of Myf5 to support myogenic differentiation without myogenin, MyoD, and MRF4.
    Valdez MR; Richardson JA; Klein WH; Olson EN
    Dev Biol; 2000 Mar; 219(2):287-98. PubMed ID: 10694423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell density-dependent induction of endogenous myogenin (myf4) gene expression by Myf5.
    Lindon C; Albagli O; Pinset C; Montarras D
    Dev Biol; 2001 Dec; 240(2):574-84. PubMed ID: 11784084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor-alpha and basic fibroblast growth factor differentially inhibit the insulin-like growth factor-I induced expression of myogenin in C2C12 myoblasts.
    Layne MD; Farmer SR
    Exp Cell Res; 1999 May; 249(1):177-87. PubMed ID: 10328964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposing functions of ATF2 and Fos-like transcription factors in c-Jun-mediated myogenin expression and terminal differentiation of avian myoblasts.
    Daury L; Busson M; Tourkine N; Casas F; Cassar-Malek I; Wrutniak-Cabello C; Castellazzi M; Cabello G
    Oncogene; 2001 Nov; 20(55):7998-8008. PubMed ID: 11753683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and subcellular localization of myogenic regulatory factors during the differentiation of skeletal muscle C2C12 myoblasts.
    Ferri P; Barbieri E; Burattini S; Guescini M; D'Emilio A; Biagiotti L; Del Grande P; De Luca A; Stocchi V; Falcieri E
    J Cell Biochem; 2009 Dec; 108(6):1302-17. PubMed ID: 19830700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delineating v-Src downstream effector pathways in transformed myoblasts.
    Ciuffini L; Castellani L; Salvati E; Galletti S; Falcone G; Alemà S
    Oncogene; 2008 Jan; 27(4):528-39. PubMed ID: 17637741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
    Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
    Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual promoter structure of ZFP106: regulation by myogenin and nuclear respiratory factor-1.
    Grasberger H; Ye H; Mashima H; Bell GI
    Gene; 2005 Jan; 344():143-59. PubMed ID: 15656981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic Ras-induced secretion of a novel inhibitor of skeletal myoblast differentiation.
    Weyman CM; Wolfman A
    Oncogene; 1997 Nov; 15(21):2521-8. PubMed ID: 9399640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.